#antibiotic-resistance

#antibiotic-resistance

Superbugs like MRSA pose significant global health risks due to rising antibiotic resistance, leading to over a million deaths annually.

Phage therapy is emerging as a viable treatment against antibiotic-resistant bacteria due to increasing resistance and the need for alternative therapies.

Antibiotic resistance leads to millions of deaths and poses a critical global health challenge, especially in developing countries.

Bacterial resistance to antibiotics is a growing global health crisis, particularly impacting low- and middle-income countries.

Antibiotic resistance is escalating, necessitating urgent local drug development, particularly in low- and middle-income countries.

Phage therapy demonstrates potential as a solution to antibiotic resistance in bacterial infections.

Microbes may travel long distances on high-level winds, highlighting the risk of antibiotic resistance spreading across regions.

Abstaining from sex is the only way to completely avoid STIs, as antibiotics are becoming increasingly ineffective against infections like gonorrhea.

Antibiotic resistance poses a serious threat to public health, potentially killing hundreds of millions over the coming decades.

Typhoid fever remains a public health threat due to antibiotic resistance and inadequate access to safe water and sanitation.

The human microbiome may harbor untapped reservoirs of antibiotic resistance genes, posing risks for public health and superbug threats.

Locus's phage therapy effectively targets and degrades E. coli bacteria, showing promising results in treating urinary tract infections (UTIs).

Antibiotic persistence allows bacterial survival under stress, complicating treatment strategies.

Over 50% of pet dogs carry antibiotic-resistant E. coli, posing a risk to humans

Superbugs in companion animals can lead to new drug-resistant diseases in people

MRSA has evolved a novel division mechanism allowing it to survive in the presence of antibiotics, crucial for developing effective treatments.

Alan Hauser, MD, PhD, awarded the 2024 Tripartite Legacy Faculty Prize for excellence in research and education in microbiology and immunology.

Surface geometry with nanoscopic needles on steel-copper material kills bacteria without antibiotics or detergents.

Phage therapy, once overlooked, is regaining interest in combating antibiotic-resistant bacterial infections.

The Longitude Prize has been awarded for a rapid infection test to combat superbugs.

The fight against superbugs involves delaying antibiotic resistance by using treatments judiciously and investing in prevention measures and new vaccines.

Researchers are exploring non-antibiotic methods to prevent recurrent UTIs, including vaccines and non-antibiotic drugs.

Oral spray vaccine can prevent recurring UTIs for up to nine years

54% of patients remained UTI-free for 9 years after using the vaccine.

AI is accelerating natural-product antibiotic discovery, yielding one million potential compounds with dozens showing promise against bacteria.

Antibiotic resistance poses a significant global health threat declared by the WHO.

Bacteria can become metabolically inert, causing recurring infections post-antibiotic treatment.